US EditionPublished • loading... • Updated
Needham & Company LLC Raises Veracyte (NASDAQ:VCYT) Price Target to $48.00
Summary by americanbankingnews.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Needham & Company LLC Raises Veracyte (NASDAQ:VCYT) Price Target to $48.00
Veracyte (NASDAQ:VCYT – Get Free Report) had its price target raised by equities researchers at Needham & Company LLC from $44.00 to $48.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The firm presently has a “buy” rating on the biotechnology company’s stock. Needham & Company LLC’s price objective would indicate […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
